Literature DB >> 8943340

Constitutive c-ets2 expression in M1D+ myeloblast leukemic cells induces their differentiation to macrophages.

C Aperlo1, P Pognonec, E R Stanley, K E Boulukos.   

Abstract

The expression of c-ets2 is rapidly induced in a variety of myelomonocytic cell lines as they differentiate into macrophages. We find that constitutive expression of c-ets2 in the M1D+ myeloblast leukemic cell line (M1ets2) is sufficient to push these cells to a more differentiated state. The expression of several differentiation-specific genes is upregulated in M1ets2 cells, including those encoding macrophage-specific lysozyme M and tumor necrosis factor alpha, which are involved in bacteriolytic and inflammatory processes, respectively. Transcription factors c-jun and junB, previously shown to induce partial macrophage differentiation when overexpressed in myelomonocytic leukemia cell lines, are also upregulated in M1ets2 cells. The upregulation of junB is the result of a direct interaction of Ets2 with ets binding sites of the junB promoter, since transient or constitutive Ets2 expression in M1D+ cells activates junB transcription via ets binding sites. In addition, transfection of a dominant negative mutant of Ets2, devoid of its transcriptional activation domain, greatly reduces transcriptional activities of the junB promoter in M1ets2 cells. Finally, unlike their parental M1D+ counterparts, M1ets2 cells secrete the macrophage colony-stimulating factor, CSF-1, and are able to phagocytize. Taken together, these results show that when the immature myeloid M1D+ cell line constitutively expresses c-ets2, these cells acquire different functions of mature macrophages.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943340      PMCID: PMC231688          DOI: 10.1128/MCB.16.12.6851

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

1.  Transforming capacities and defectiveness of avian leukemia viruses OK10 and E 26.

Authors:  T Graf; N Oker-Blom; T G Todorov; H Beug
Journal:  Virology       Date:  1979-12       Impact factor: 3.616

2.  The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.

Authors:  C J Sherr; C W Rettenmier; R Sacca; M F Roussel; A T Look; E R Stanley
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

3.  Myeloid and erythroid neoplastic responses to avian defective leukemia viruses in chickens and in quail.

Authors:  C Moscovici; J Samarut; L Gazzolo; M G Moscovici
Journal:  Virology       Date:  1981-09       Impact factor: 3.616

4.  An SV40 "enhancer trap" incorporates exogenous enhancers or generates enhancers from its own sequences.

Authors:  F Weber; J de Villiers; W Schaffner
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

5.  A putative second cell-derived oncogene of the avian leukaemia retrovirus E26.

Authors:  D Leprince; A Gegonne; J Coll; C de Taisne; A Schneeberger; C Lagrou; D Stehelin
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

6.  Characterization of the hemopoietic target cells for the avian leukemia virus E26.

Authors:  M G Moscovici; P Jurdic; J Samarut; L Gazzolo; C V Mura; C Moscovici
Journal:  Virology       Date:  1983-08       Impact factor: 3.616

7.  Control of lysozyme induction in the differentiation of myeloid leukemic cells.

Authors:  A Krystosek; L Sachs
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

8.  Isolation and characterization of a cloned growth factor dependent macrophage cell line, BAC1.2F5.

Authors:  C Morgan; J W Pollard; E R Stanley
Journal:  J Cell Physiol       Date:  1987-03       Impact factor: 6.384

9.  The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: both loci are transcriptionally active.

Authors:  D K Watson; M J McWilliams-Smith; M F Nunn; P H Duesberg; S J O'Brien; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Tripartite structure of the avian erythroblastosis virus E26 transforming gene.

Authors:  M F Nunn; P H Seeburg; C Moscovici; P H Duesberg
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

View more
  9 in total

1.  Hematopoietic fingerprints: an expression database of stem cells and their progeny.

Authors:  Stuart M Chambers; Nathan C Boles; Kuan-Yin K Lin; Megan P Tierney; Teresa V Bowman; Steven B Bradfute; Alice J Chen; Akil A Merchant; Olga Sirin; David C Weksberg; Mehveen G Merchant; C Joseph Fisk; Chad A Shaw; Margaret A Goodell
Journal:  Cell Stem Cell       Date:  2007-11       Impact factor: 24.633

2.  Regulation of expression of the human beta-1,2-N-acetylglucosaminyltransferase II gene (MGAT2) by Ets transcription factors.

Authors:  W Zhang; L Revers; M Pierce; H Schachter
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

Review 3.  Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide beta(1,6) branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential.

Authors:  M Pierce; P Buckhaults; L Chen; N Fregien
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

4.  The Ets2 transcription factor inhibits apoptosis induced by colony-stimulating factor 1 deprivation of macrophages through a Bcl-xL-dependent mechanism.

Authors:  L Sevilla; C Aperlo; V Dulic; J C Chambard; C Boutonnet; O Pasquier; P Pognonec; K E Boulukos
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

5.  The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

Authors:  J A Brown; E M Rogers; J M Boss
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

Review 6.  ETS transcription factors in embryonic vascular development.

Authors:  Michael P Craig; Saulius Sumanas
Journal:  Angiogenesis       Date:  2016-04-28       Impact factor: 9.596

7.  The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy.

Authors:  Y Ge; K M LaFiura; A A Dombkowski; Q Chen; S G Payton; S A Buck; S Salagrama; A E Diakiw; L H Matherly; J W Taub
Journal:  Leukemia       Date:  2007-12-20       Impact factor: 11.528

8.  Socs3 maintains the specificity of biological responses to cytokine signals during granulocyte and macrophage differentiation.

Authors:  Ben A Croker; Lisa A Mielke; Sam Wormald; Donald Metcalf; Hiu Kiu; Warren S Alexander; Douglas J Hilton; Andrew W Roberts
Journal:  Exp Hematol       Date:  2008-04-08       Impact factor: 3.084

9.  A novel 110 kDa form of myosin XVIIIA (MysPDZ) is tyrosine-phosphorylated after colony-stimulating factor-1 receptor signalling.

Authors:  Maddalena Cross; Xavier F Csar; Nicholas J Wilson; Gaël Manes; Theresa A Addona; Denese C Marks; Genevieve A Whitty; Keith Ashman; John A Hamilton
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.